Skip to main content
. 2021 Jul;10(7):3132–3143. doi: 10.21037/tlcr-21-198

Table 4. Tumor responses to systemic therapy.

Tumor response ALL systemic therapy ILD recurrence No ILD recurrence P value
PR 3 1 2
SD 13 2 11
PD 13 6 7
NE 5 1 4
ORR 9% 10% 8% 0.88a
DCR 47% 30% 54% 0.47a

Differences between groups were identified using aChi-Square test. ILD, interstitial lung disease; PR, partial response; SD, stable disease; PD, progressive disease; NE, not evaluable; ORR, overall response rate; DCR, disease control rate.